Oosterbaan HP et al. |
The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women. |
1995 |
Maturitas |
pmid:7616870
|
Cagnacci A et al. |
A comparison of the central effects of different progestins used in hormone replacement therapy. |
2004 |
Maturitas |
pmid:15283939
|
Lazar F et al. |
Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users. |
2004 |
Maturitas |
pmid:15283941
|
Norman-Taylor JQ et al. |
Hormone replacement therapy by the transdermal administration of oestradiol and norethisterone. |
1994 |
Maturitas |
pmid:8015505
|
Kurtay G et al. |
A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women. |
2006 |
Maturitas |
pmid:16325022
|
Klehr-Bathmann I and Kuhl H |
Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate. |
1995 |
Maturitas |
pmid:7616874
|
Kaiser R |
Duration of the climacteric syndrome in women treated by hormonal substitution and in controls. |
1984 |
Maturitas |
pmid:6727694
|
Campagnoli C et al. |
Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. |
1994 |
Maturitas |
pmid:7935029
|
Nordin BE et al. |
A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women. |
1980 |
Maturitas |
pmid:7003315
|
Lundström E et al. |
Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. |
2011 |
Maturitas |
pmid:21958943
|
Perry W and Wiseman RA |
Combined oral estradiol valerate-norethisterone treatment over 3 years in postmenopausal women: effect on lipids, coagulation factors, haematology and biochemistry. |
2002 |
Maturitas |
pmid:12065175
|
Pedersen NG et al. |
Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits. |
2004 |
Maturitas |
pmid:15531126
|
Piccioni P et al. |
Hormonal replacement therapy after stem cell transplantation. |
2004 |
Maturitas |
pmid:15531129
|
Samsioe G et al. |
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. |
2007 |
Maturitas |
pmid:17317046
|
Franke HR and Vermes I |
Differential effects of progestogens on breast cancer cell lines. |
2003 |
Maturitas |
pmid:14670646
|
Christodoulacos G et al. |
Transvaginal sonographic monitoring of the uterine effects of raloxifene and a continuous combined replacement therapy in postmenopausal women. |
2002 |
Maturitas |
pmid:12020983
|
Norris LA et al. |
Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy. |
2002 |
Maturitas |
pmid:12385861
|
Brynhildsen J and Hammar M |
Lipids and clotting factors during low dose transdermal estradiol/norethisterone use. |
2005 |
Maturitas |
pmid:15780536
|
Volpe A et al. |
Benefits and risks of different hormonal replacement therapies in post-menopausal women. |
1986 |
Maturitas |
pmid:3033444
|
Bjarnason K et al. |
Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. |
1999 |
Maturitas |
pmid:10515673
|
Seeger H et al. |
In vitro effects of tibolone and its metabolites on human vascular coronary cells. |
2007 |
Maturitas |
pmid:17572028
|
Fink BJ |
Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen. |
1984 |
Maturitas |
pmid:6738374
|
Bruhat M et al. |
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study. |
2001 |
Maturitas |
pmid:11731187
|
Eilertsen AL et al. |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis. |
2005 |
Maturitas |
pmid:16186073
|
Sporrong T et al. |
A novel statistical approach to analysis of bleeding patterns during continuous hormone replacement therapy. |
1989 |
Maturitas |
pmid:2593864
|
Yilmazer M et al. |
Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. |
2003 |
Maturitas |
pmid:14625121
|
Cengiz B et al. |
Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women. |
2003 |
Maturitas |
pmid:14625127
|
Nerbrand C et al. |
Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides. |
2002 |
Maturitas |
pmid:12020980
|
Ruan X et al. |
The pharmacology of dienogest. |
2012 |
Maturitas |
pmid:22364708
|
Polisseni AF et al. |
Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. |
2013 |
Maturitas |
pmid:23201326
|
Christiansen C et al. |
Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment. |
1984 |
Maturitas |
pmid:6727693
|
Christodoulakos G et al. |
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. |
2005 |
Maturitas |
pmid:15780533
|
Riis BJ et al. |
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women. |
1988 |
Maturitas |
pmid:3041248
|
Grasso A et al. |
Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy. |
1982 |
Maturitas |
pmid:6285153
|
Dahmoun M et al. |
Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT. |
2004 |
Maturitas |
pmid:15474755
|
Christodoulakos GE et al. |
The effect of low dose hormone therapy on mammographic breast density. |
2006 |
Maturitas |
pmid:16198519
|
von Holst T et al. |
Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone. |
2002 |
Maturitas |
pmid:12468135
|
Fernandes CE et al. |
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow. |
2008 |
Maturitas |
pmid:18359175
|
Thunell L et al. |
The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes. |
2006 |
Maturitas |
pmid:16198072
|
Luotola H et al. |
Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women. |
1986 |
Maturitas |
pmid:3537636
|
Zhou J et al. |
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. |
2013 |
Maturitas |
pmid:23856385
|
Riis BJ and Christiansen C |
Post-menopausal bone loss: effects of oestrogens and progestogens. A review. |
1986 |
Maturitas |
pmid:3553863
|
al-Azzawi F et al. |
Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50. |
1994 |
Maturitas |
pmid:8177092
|
Posaci C et al. |
Effects of HRT on serum levels of IGF-I in postmenopausal women. |
2001 |
Maturitas |
pmid:11684375
|
Lübbert H and Nauert C |
Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern. |
1997 |
Maturitas |
pmid:9522319
|
Gambacciani M et al. |
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. |
2003 |
Maturitas |
pmid:12590012
|
Glusa E et al. |
Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. |
1997 |
Maturitas |
pmid:9522326
|
Peverill RE et al. |
Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women. |
2006 |
Maturitas |
pmid:16368469
|
Popp AW et al. |
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. |
2006 |
Maturitas |
pmid:16368472
|
Stadberg E et al. |
17 beta-estradiol and norethisterone acetate in low doses as continuous combined hormone replacement therapy. |
1996 |
Maturitas |
pmid:8861084
|
Raudaskoski TH et al. |
Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device. |
1995 |
Maturitas |
pmid:7666816
|
Lindgren R et al. |
Transdermal hormonal replacement therapy with transdermal progestin every second month. |
1995 |
Maturitas |
pmid:7666813
|
Byrjalsen I et al. |
Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status. |
1990 |
Maturitas |
pmid:2255265
|
Saarikoski S et al. |
Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders. |
1990 |
Maturitas |
pmid:2255266
|
Dören M and Schneider HP |
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women. |
1996 |
Maturitas |
pmid:8905600
|
Mattsson LA et al. |
Evaluation of a continuous oestrogen-progestogen regimen for climacteric complaints. |
1982 |
Maturitas |
pmid:7121296
|
Schindler AE et al. |
Classification and pharmacology of progestins. |
2003 |
Maturitas |
pmid:14670641
|
Jensen J et al. |
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women. |
1989 |
Maturitas |
pmid:2547137
|
Need AG et al. |
Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis. |
1986 |
Maturitas |
pmid:3574140
|
Campagnoli C et al. |
Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate. |
2002 |
Maturitas |
pmid:12034517
|
Obel EB et al. |
A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment. |
1993 |
Maturitas |
pmid:8429800
|
Hellberg D and Nilsson S |
Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints. |
1984 |
Maturitas |
pmid:6429481
|
Keller PJ et al. |
A transdermal regimen for continuous combined hormone replacement therapy in the menopause. |
1992 |
Maturitas |
pmid:1465033
|
Mehring W |
[The effect of ovulation inhibitors on the vaginal picture and the portio epithelium]. |
1965 |
Med Klin |
pmid:5870226
|
|
Norethindrone--the "minipill". |
1973 |
Med Lett Drugs Ther |
pmid:4712978
|
|
Norinyl 1+80 and Ortho-Novum 1/80. |
1969 |
Med Lett Drugs Ther |
pmid:5778361
|
|
Ortho-Novum 10/11--a new "bi-phasic" oral contraceptive. |
1982 |
Med Lett Drugs Ther |
pmid:7121396
|
|
Three new combination oral contraceptives: Seasonique, Loestrin 24 Fe, and Yaz. |
2006 |
Med Lett Drugs Ther |
pmid:17001297
|
Lachnit-Fixson U and Aydinlik S |
[New cycle-stabilizing contraceptive agent (Ediwal)]. |
1976 |
Med Monatsschr |
pmid:979900
|
Zaffaroni A |
Systems for controlled drug delivery. |
1981 |
Med Res Rev |
pmid:7050567
|
GOLDFARB AF et al. |
OVULATION CONTROL. |
1963 |
Med Sci |
pmid:14081010
|
DEHAEN P |
THERAPEUTIC RESEARCH IN REVIEW. |
1964 |
Med Sci |
pmid:14143127
|
Ranneberg KM and Holzmann H |
[Herpes gestationis recurrence caused by synthetic gestagens]. |
1970 |
Med Welt |
pmid:4249079
|
HEINEN G |
[Oral contraception]. |
1962 |
Med Welt |
pmid:13953432
|
GOLDZIEHER JW |
NEWER DRUGS IN ORAL CONTRACEPTION. |
1964 |
Med. Clin. North Am. |
pmid:14149247
|
Stoll BA |
Therapy by progestational agents in advanced breast cancer. |
1966 |
Med. J. Aust. |
pmid:5906684
|
CUNINGHAM K and LANG WR |
Result of a blind clinical trial conducted on 50 cases of hormonal mastopathy. |
1962 |
Med. J. Aust. |
pmid:14024258
|
Roxburgh DR and West MJ |
The use of norethisterone to suppress menstruation in the intellectually severely retarded woman. |
1973 |
Med. J. Aust. |
pmid:4746398
|
Kneale B and Evans J |
Progestogen therapy for advanced carcinoma of the endometrium. |
1969 |
Med. J. Aust. |
pmid:5374044
|
Fraser IS and Weisberg E |
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. |
1981 |
Med. J. Aust. |
pmid:6453269
|
MacLennan AH et al. |
Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial. |
1993 |
Med. J. Aust. |
pmid:8336583
|
PLANT GH |
PRODUCTION AND QUALITY CONTROL OF AN ORAL CONTRACEPTIVE. |
1965 |
Med. J. Aust. |
pmid:14265218
|
BROWN MM |
PREMENSTRUAL METATARSALGIA. |
1965 |
Med. J. Aust. |
pmid:14315259
|
Wren BG |
Minimal dose combined hormonal replacement therapy for menopausal women. |
1981 |
Med. J. Aust. |
pmid:7242418
|
Gattanell PN et al. |
Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives. |
1978 |
Med. Pediatr. Oncol. |
pmid:207962
|
Czarnecka D et al. |
The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. |
2004 |
Med. Sci. Monit. |
pmid:14737044
|
Kyriakou A and Skordis N |
Thalassaemia and aberrations of growth and puberty. |
2009 |
Mediterr J Hematol Infect Dis |
pmid:21415985
|
Georgiev DB and Manassiev NA |
Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women. |
2002 Jul-Aug |
Medscape Womens Health |
pmid:12466733
|
Krämer EA et al. |
The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. |
2005 Jul-Aug |
Menopause |
pmid:16037763
|
Speroff L et al. |
The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms. |
2000 Nov-Dec |
Menopause |
pmid:11127760
|
Brynhildsen J and Hammar M |
Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. |
2002 Mar-Apr |
Menopause |
pmid:11875333
|
Christodoulakos GE et al. |
The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. |
2004 May-Jun |
Menopause |
pmid:15167309
|
Dören M et al. |
Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. |
1999 |
Menopause |
pmid:10614676
|
Samsioe G et al. |
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate. |
2002 Sep-Oct |
Menopause |
pmid:12218722
|
Mueck AO et al. |
Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. |
2002 Jul-Aug |
Menopause |
pmid:12082363
|
Seeger H et al. |
Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. |
2001 Jan-Feb |
Menopause |
pmid:11201515
|
Ursic-Vrscaj M et al. |
Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival. |
2001 Jan-Feb |
Menopause |
pmid:11201519
|
Botteman MF et al. |
A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms. |
2004 May-Jun |
Menopause |
pmid:15167315
|
Vitale C et al. |
Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy. |
2005 Sep-Oct |
Menopause |
pmid:16145309
|
Rinaldi M et al. |
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis. |
2005 Sep-Oct |
Menopause |
pmid:16145317
|